- idUS
- Listar por autor
Listar por autor "Merino Bohórquez, Vicente"
Mostrando ítems 21-23 de 23
-
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
Argüelles Arias, Federico; Guerra Veloz, María Fernanda; Perea Amarillo, Raúl; Vilches Arenas, Ángel; Castro Laria, Luisa; Maldonado Pérez, Belén; Merino Bohórquez, Vicente; Romero Gómez, Manuel (Lippincott Williams & Wilkins, 2017)Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory ...
-
Artículo
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
Marín Candón, Alicia; Rosso Fernández, Clara María; Bustos de Godoy, Natalia; López Cerero, Lorena; Gutiérrez Gutiérrez, Belén; López Cortés, Luis Eduardo; Merino Bohórquez, Vicente; Retamar Gentil, Pilar; Pascual Hernández, Álvaro; Rodríguez-Baño, Jesús (BMJ Publishing Group, 2021)Introduction: Alternatives to carbapenems are needed in the treatment of third-generation cephalosporin-resistant ...
-
Artículo
Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease
Salvador-Martín, Sara; Kaczmarczyk, Bartosz; Álvarez, Rebeca; Navas-López, Víctor Manuel; Gallego-Fernández, Carmen; Moreno-Álvarez, Ana; Merino Bohórquez, Vicente; López-Fernández, Luís A. (MDPI, 2021-01-08)Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis ...